Sampling Dates, Analysis Dates and Report Dates
Separate the events
Several dates can appear on a single certificate because several events occurred. Sampling is when material was selected. Receipt is when the laboratory accepted it. Analysis may cover one day or several runs. Issue is when the report was authorised or released. Record each event under its own heading.
For UK records that may be shared internationally, write dates unambiguously, for example 12 September 2026. Preserve the original date format too if a source document could be read in more than one way. Do not resolve an ambiguous date by assumption.
Ask what happened between dates
A timeline becomes useful when it includes the material’s history. Was the submitted sample retained before dispatch? Was analysis delayed? Was a report reissued after an administrative correction? None of these events proves a problem, but each can affect the question the document answers.
The sampling framework in Eurachem’s uncertainty-from-sampling guide includes preparation as well as measurement. As a practical extension, record relevant transport or storage information with the dates rather than treating the instrument run as the material’s entire history.
Do not turn a report into an expiry claim
A report issued last week might describe an analysis performed months earlier. A date on that report is not automatically a retest date, shelf-life statement or guarantee of present condition. Those conclusions require the appropriate evidence for the material and circumstances.
The dating and stability sections in ICH Q7 treat these as distinct topics. This pharmaceutical reference helps explain the distinction; it does not establish a shelf life for an unspecified research peptide. Request the basis of any supplier dating statement separately.
Write the timeline you can support
Create one line for sampling, receipt, analysis and issue, adding “not stated” where necessary. Link every entry to its source. If an amended document arrives, keep the earlier version and note whether the amendment changed a date, a result or only presentation.
Compare the document in the COA library with your own receipt record. If a long interval could matter for the planned assay, ask the supplier or laboratory a focused question about that interval.
The final review should say which sample the timing describes and which later events remain outside the report. An honest incomplete timeline is more useful than a confident one constructed from dates that mean different things.
Related research reading
- Laboratory Accreditation: Read the Scope, Not Just the Badge
- What Raw Analytical Data Adds to a Short Certificate
Explore the research blog and original batch-document library for further context.
Sources
What Raw Analytical Data Adds to a Short Certificate
Identify the question behind the request
“Please send the raw data” can mean very different things to a supplier and a laboratory. One party may send a screenshot; another may offer instrument files that require specialist software. Begin with the uncertainty you want to resolve: peak assignment, signal processing, a calculation or the connection between a sample and a result.
Ask what files exist and which are original observations, processed outputs or summaries. A PDF chromatogram may be useful, but its appearance does not tell you whether processing settings or acquisition metadata have been retained elsewhere.
Look beyond the picture
A chromatographic trace needs context: sample reference, analytical method, detector channel, relevant axes and the integration used for the stated calculation. A mass spectrum likewise needs an explanation of what the displayed signal represents and how it supports the reported assignment. These are review questions, not a recipe for reproducing a method.
The laboratory-record section of ICH Q7 discusses underlying analytical records. Its pharmaceutical setting should be recognised. A research buyer can still ask which evidence supports the particular summary supplied, without assuming every file must be publicly downloadable.
Keep processing history in view
A result may change when data are reprocessed. Ask whether the supplied output is the version used for the certificate and whether relevant changes have been documented. A disagreement between two PDFs may reflect a revision, different processing or a different sample; the images alone may not resolve it.
The OECD data-integrity document provides a primary reference for considering data through their life cycle. Preserve the explanatory correspondence with the analytical files so that later reviewers can understand why a particular output was accepted.
Make a proportionate review
For an initial screen, a complete report and intelligible supporting plots may answer the question. A contested result or method transfer may require deeper discussion with the laboratory, including access to native files and appropriately qualified review. More files do not automatically create a better conclusion.
Start with the available material in the COA library and record what remains unavailable. Do not infer unreported identity, content or microbiological properties from a single attractive trace.
Finish by writing what the added evidence established, what it did not establish and whether the remaining uncertainty matters for the planned study. That short assessment makes the request for raw data useful rather than merely accumulating attachments.
Related research reading
Explore the research blog and original batch-document library for further context.
Sources
Report Numbers, Batch Numbers and Sample Identifiers
Give each number a job
A report number identifies a document or reporting event. A batch number identifies a defined production grouping under the producer’s system. A sample identifier tracks the item received or created by a laboratory. These numbers may appear together, but they are not interchangeable.
A purchase-order number adds another layer: it connects a transaction with your organisation. It usually cannot, on its own, establish which sample was analysed. Write the identifier’s owner and purpose beside the value rather than maintaining a single spreadsheet column called “reference”.
Draw the relationships
Imagine two vials from one supplier lot sent to different laboratories. They could share the supplier batch code while receiving separate laboratory sample numbers and separate report references. Conversely, one report might contain results for several samples. Read the document structure before assuming a one-to-one relationship.
For a useful pharmaceutical reference, ICH Q7 covers laboratory records and certificates. For ordinary research purchasing, design a small mapping table linking supplier code, physical stock identifier, submitted sample and report. Include the source of each connection.
Handle revisions explicitly
A revised report can retain its original number and gain a revision suffix, or receive a replacement number. Ask the issuing laboratory how its system works. Record which version supersedes which, the stated reason for amendment and whether any analytical result changed.
The wider records perspective in OECD’s GLP data-integrity publication is relevant when planning this audit trail. That does not make an internal spreadsheet GLP compliant; it helps identify the context that should remain understandable when staff or software change.
Use the mapping during research
At receipt, give each physical item a local stock reference without covering the original label. At testing, record which item supplied the sample and whether it was opened, divided or pooled. At reporting, attach the laboratory result to that submitted sample first. Any extension to other stock needs its own justification.
The COA library can help locate supporting files, while your local register supplies the delivery-specific relationships. Before an experiment is recorded, check that the notebook references both the material and the actual document reviewed.
If two codes disagree, retain both and investigate the difference. Changing one to make the table look consistent can destroy the very clue needed to resolve a mix-up. Clear relationships matter more than a visually tidy list of numbers.
Related research reading
- What Raw Analytical Data Adds to a Short Certificate
- What a Redacted Batch Field Means for Traceability
Explore the research blog and original batch-document library for further context.
Sources
What a Redacted Batch Field Means for Traceability
Describe what is actually missing
When a batch number is obscured on a certificate, the document may still show methods, dates and analytical results. What it cannot visibly show is the complete identifier in that field. That distinction matters: neither a favourable number nor a professional layout restores information that has been removed.
Describe the omission precisely. “Supplier lot field redacted on public PDF” is a useful observation. “Untraceable product” may go beyond the available evidence if a private mapping exists; “verified batch” also goes too far if nobody has checked that mapping.
Ask for a controlled explanation
Request confirmation of what was redacted, why the public version differs and what route permits verification. Depending on the circumstances, a laboratory might receive an unredacted report, review it under an agreed access arrangement or obtain a documented identifier mapping. The appropriate option depends on the research organisation’s requirements.
The batch-identification discussion in ICH Q7’s certificate guidance explains why this field matters. It is pharmaceutical guidance, not a blanket legal requirement for every research material sold in Britain. Use it to frame the question rather than to invent a certification claim.
Preserve both versions
Keep the public document and any later clarification together, with dates and a note explaining their relationship. Do not replace the original file silently with a new one carrying different information. A future reviewer should be able to understand which version informed an experimental decision.
The OECD publication on data integrity addresses data across their life cycle. In a practical research file, that suggests retaining context alongside the visible result. A covering email can be valuable evidence of a mapping, but its authority and specificity still need assessment.
Make the limitation usable
For a procurement review, write down the exact consequence of the missing field. Perhaps the laboratory can assess the reported technique but cannot yet assign the report to its stock. That is a concrete unresolved task, not a reason to speculate about the result.
Consult the COA library alongside your receipt records. If a report cannot be linked adequately, follow your local review procedure before relying on it. Redaction itself neither proves misconduct nor establishes authenticity; the quality of the supporting connection determines what can reasonably be concluded.
Related research reading
- Report Numbers, Batch Numbers and Sample Identifiers
- Matching a Certificate of Analysis to a Vial Label
Explore the research blog and original batch-document library for further context.
Sources
Matching a Certificate of Analysis to a Vial Label
Start with the physical item
A certificate of analysis may carry an impressive result yet still leave a basic question unanswered: does it describe the vial in front of you? Begin by recording the label exactly as received. Include the product name, stated amount, batch or lot code and any separate packaging identifier. Preserve leading zeros, punctuation and letter case rather than tidying them into a preferred format.
Photograph the label and keep the delivery record with it. A photograph provides a useful reference if a label later becomes damaged, but it does not establish chemical identity. The immediate aim is a readable record of what arrived at your UK laboratory.
Build the link between identifiers
Compare those observations with the certificate, including its material description and batch field. ICH Q7’s certificate section identifies batch numbers as certificate information. That guidance concerns pharmaceutical ingredients; it is a useful reference rather than evidence that a research supplier follows GMP.
Different codes need an explanation, not a guess. A supplier lot, manufacturer lot and laboratory sample number can legitimately coexist. Request a written mapping showing which identifier belongs to which organisation and how the particular delivered item connects to the tested sample. Similar product names alone cannot supply that missing link.
Keep uncertainty visible
A blank or redacted batch field limits what a public certificate can demonstrate. Record the gap and request a version or supporting statement that allows an authorised reviewer to verify the connection. Do not insert an inferred number into the original document. OECD’s data-integrity guidance provides a wider framework for preserving meaningful records.
For example, a certificate downloaded for a previous order should not automatically be assigned to a later delivery of the same named peptide. Keep both deliveries separate until their identifiers have been checked. Record who provided clarification and the date it was received.
Finish with a review decision
Use the COA library as a document starting point, then retain the exact file reviewed. Write a short conclusion: matched through stated identifiers, matched through a documented mapping, or unresolved. This is more informative than a folder simply labelled “passed”.
If the link remains unresolved, decide under your laboratory’s procedures whether additional documentation or testing is needed before the planned experiment. A matched certificate improves traceability; the reported tests still need separate assessment for relevance, method and limitations.
Related research reading
- What a Redacted Batch Field Means for Traceability
- Independent Testing Starts with the Sample That Was Sent
Explore the research blog and original batch-document library for further context.
Sources
Before Choosing a Research Supplier: Build a Document Trail
Use identity, traceability, test scope and practical delivery information to organise a supplier assessment without relying on badges or broad quality claims.
Assess records, not a collection of badges
A supplier assessment becomes more useful when it produces a document trail. Begin with a clear material specification, then list the evidence needed to support it. Marketing descriptions can help identify questions, but they should not substitute for answers that can be matched to a particular compound, batch and delivery.
Connect identity and traceability
Request the full material description and the identifiers used on the packaging and reports. Record how the supplier links a certificate to the material offered. A missing, redacted or generic batch field limits that connection. Where several vial strengths share a compound name, check that the document concerns the correct format and does not merely describe a related listing.
Check the scope of the quality claim
Ask which laboratory performed the work and what the method measured. Consider whether identity, content and other relevant questions have been addressed separately. A result marked “outside range” needs its original qualification preserved. If a claim mentions accreditation or a particular manufacturing standard, establish the exact organisation, activity and evidence to which the claim applies; do not infer a blanket endorsement.
Include the practical transaction
Written delivery charges, destinations, dispatch information, contact details and complaint routes also belong in the assessment. Our delivery page states the current charges and distinguishes them from dispatch details that remain unconfirmed. Regulatory status should be checked using appropriate official resources, not inferred from a “research use only” phrase. The CoA library and analytical guide support document review, but a purchasing decision still depends on the actual material and the laboratory’s requirements. Keep unanswered questions in the record rather than filling them with assumptions.
Sources and further reading
Continue reading
- Reading Peptide Test Results: Evidence Beyond a Purity Number
- Research Use Only: Separating Catalogue Information from Clinical Evidence
Browse all research articles or visit the research library.
Research Use Only: Separating Catalogue Information from Clinical Evidence
Understand the difference between a research catalogue entry, a scientific finding and evidence or authorisation for a clinical use.
Begin with intended use
A research catalogue describes materials for a defined research context. It should not be read as a source of personal treatment advice. On Edinburgh Peptide, the stated scope is in-vitro laboratory research, not human or veterinary use. That limitation belongs alongside the actual claims and information presented about a product, rather than being treated as a phrase that changes the meaning of everything else on a page.
A paper and a product are different objects
A publication reports work conducted under particular conditions with specified material. Its findings do not automatically transfer to a separate commercial vial, an alternative formulation or a different purpose. Even a well-designed clinical study is not evidence that an unrelated catalogue material has the same manufacturing controls, composition or regulatory status.
Labelling does not settle every regulatory question
The MHRA’s borderline-products guidance explains that medicinal-product classification requires consideration of the product and its presentation and function. A short disclaimer is not a substitute for that assessment. A research summary should therefore describe the actual experimental context and avoid implying a therapeutic benefit merely because a molecule appears in the medical literature.
Keep the practical boundaries visible
Record what the catalogue entry specifies and which questions remain open. Review batch identity and analytical documents separately from clinical claims. Do not use a product page as an administration protocol, and do not assume that “research” means all handling questions have already been resolved. Our research-use disclaimer sets out this site’s scope; the research library explains how to evaluate source limitations. Where a decision involves regulation or clinical care, obtain advice from the appropriately qualified professional rather than relying on a supplier article.
Sources and further reading
Continue reading
- Before Choosing a Research Supplier: Build a Document Trail
- From Peptide Name to Chemical Identity: Reading a Specification
Browse all research articles or visit the research library.
Why “99% Purity” Is Not a Complete Peptide Specification
Learn why chromatographic purity, peptide quantity, identity and contamination testing must not be treated as interchangeable measurements.
A percentage needs a definition
Before interpreting a purity claim, establish what was measured and how the percentage was calculated. A number without its method, detector and calculation basis is incomplete information. In particular, a chromatographic peak-area percentage should not automatically be read as the fraction of the entire vial’s mass that is the desired peptide.
Different questions require different evidence
Identity asks what the material is. Quantitative content asks how much of a defined analyte is present. A chromatographic assessment describes responses under a separation method. Other quality questions may concern residual solvents, water, microorganisms or endotoxin. One favourable result does not answer the others, and an untargeted issue cannot be ruled out simply because it was not discussed on a short certificate.
Read the denominator and the method’s scope
Consider which signals were included, how peaks were integrated and whether relevant components were resolved or detected. Detector response is not necessarily identical for every substance. The ICH validation framework is helpful because it asks whether a procedure is fit for its intended analytical purpose. It does not turn a headline percentage into a universal certificate of suitability.
Use cautious, reproducible language
A sound record might state that a laboratory reported a particular chromatographic result for an identified sample, with the report attached. That is more precise than declaring a batch “safe” or “fully tested”. If a report contains an out-of-range result, a redaction or a qualification, retain it in the interpretation. Our certificate library keeps original report details visible, and the quality guide explains the companion checks. Research-use labelling and a high percentage do not establish suitability for human or veterinary use.
Sources and further reading
Continue reading
- Reading Peptide Test Results: Evidence Beyond a Purity Number
- Before Choosing a Research Supplier: Build a Document Trail
Browse all research articles or visit the research library.